AEM Holdings Full Year 2024 Earnings: Beats Expectations

AEM Holdings (SGX:AWX) Full Year 2024 Results

Key Financial Results

• Revenue: S$380.4m (down 21% from FY 2023).
• Net income: S$11.4m (up from S$1.24m loss in FY 2023).
• Profit margin: 3.0% (up from net loss in FY 2023). The move to profitability was driven by lower expenses.
• EPS: S$0.037 (up from S$0.004 loss in FY 2023).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

AEM Holdings Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 4.4%. Earnings per share (EPS) also surpassed analyst estimates by 24%.

The primary driver behind last 12 months revenue was the Test Cell Solutions (TCS) segment contributing a total revenue of S$231.0m (61% of total revenue). Notably, cost of sales worth S$282.8m amounted to 74% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to S$56.4m (65% of total expenses). Explore how AWX's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Semiconductor industry in Asia.

Performance of the market in Singapore.

The company's shares are down 18% from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of AEM Holdings' balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.